Roquefort Investments PLC Update on Acquisition of Lyramid Limited (2223S)
November 12 2021 - 2:33AM
UK Regulatory
TIDMROQ
RNS Number : 2223S
Roquefort Investments PLC
12 November 2021
12 November 2021
Roquefort Investments plc
("Roquefort Investments" or the "Company")
Update on Acquisition of Lyramid Limited
Roquefort Investments (LSE:ROQ), the London listed investment
company established to acquire businesses focused on early-stage
opportunities in the medical biotechnology sector , is pleased to
announce that it has commenced marketing to potential investors to
fund the acquisition and pre-clinical drug development programme of
Lyramid Limited, details of which were announced on 29 September
2021. A copy of the presentation is available on the Company's
website at https://www.roquefortinvest.com/presentations
The Company looks forward to providing further updates in
relation to the acquisition of Lyramid Limited as and when
appropriate.
The Company's shares remain suspended from trading on the Main
Market of the London Stock Exchange pending the publication of a
Prospectus setting out full details of the potential
transaction.
Enquiries:
Roquefort Investments plc
+44 (0)20 3290
Stephen West (Chairman) 9339
Optiva Securities Limited (Joint
Broker)
+44 (0)20 3411
Christian Dennis 1881
For further information, please visit www.roquefortinvest.com
and @roquefortinvest on Twitter.
LEI: 254900P4SISIWOR9RH34
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ACQBTBRTMTTBMLB
(END) Dow Jones Newswires
November 12, 2021 02:33 ET (07:33 GMT)
Roquefort Therapeutics (LSE:ROQ)
Historical Stock Chart
From Jun 2024 to Jul 2024
Roquefort Therapeutics (LSE:ROQ)
Historical Stock Chart
From Jul 2023 to Jul 2024